X

Health Care

Earnings preview: Regeneron set for a blockbuster quarter amid robust sales

Regeneron Pharmaceuticals (Nasdaq: REGN) will be reporting earnings for the first quarter Tuesday before the opening bell. Market watchers are…

Immunogen Inc (NASDAQ: IMGN) Q1 2019 Earnings Call Transcript

Immunogen Inc (IMGN) Q1 2019 earnings call dated May 03, 2019 Corporate Participants: Sarah Kiely -- Director of Investor Relations Mark Enyedy -- President and Chief…

Wall Street expects a revenue surge from GW Pharmaceuticals in Q1

Medical marijuana company GW Pharmaceuticals (NASDAQ: GWPH) is scheduled to report first-quarter 2019 earnings results on May 6, Monday, after…

Novo Nordisk’s (NYSE: NVO) profit declines 3% in Q1 2019

Denmark-based healthcare giant Novo Nordisk (NYSE: NVO, CPH: NOVO-B) reported its first quarter 2019 results today. Novo Nordisk's profit dropped…

ImmunoGen reports 57% decline in Q1 revenue

ImmunoGen Inc (NASDAQ: IMGN) on Friday reported weaker-than-expected top line in Q1, as the biotech firm continued to burn money…

Gilead Sciences tops Q1 earnings estimate, reiterates full-year outlook

Shares of Gilead Sciences (NASDAQ: GILD) gained 1.2% after the biotechnology firm reported first-quarter earnings of $1.76 per share, surpassing…

Novavax beats Q1 revenue estimates while earnings come in line

Novavax Inc. (NASDAQ: NVAX) topped market estimates on revenue for the first quarter of 2019 while earnings matched expectations. Analysts…

ImmunoGen is cheap ahead of Q1 earnings, but is it worth?

ImmunoGen Inc (NASDAQ: IMGN) is one of the worst performing stocks out there, losing about 78% of its value over…

Earnings: Cigna posts upbeat Q1 results

Cigna Corp. (NYSE: CI) reported a 50% jump in earnings for the first quarter of 2019 as continued strong business…

Teva Pharma sinks on Q1 revenue miss amid generic competition; earnings beat

Drugmaker Teva Pharmaceutical (NYSE: TEVA) reported a decline in first-quarter adjusted earnings, owing to a 15% fall in revenues as…